Trump's Tariff Policy on Generic Medicines Causes Indian Pharma Stocks to Crash

24 July 2026 at 3:19 pmHyperFast News

#Trump #Tariff Policy #Pharma Stocks #Abbott India #Ajanta Pharma #Alembic #Indian Exporters

Summary

Indian pharma stocks, including Abbott India, Ajanta Pharma, and Alembic, crashed up to 4% after President Trump announced a phased tariff plan on imported generic medicines, raising concerns for Indian exporters.

Trump's Tariff Policy on Generic Medicines Causes Indian Pharma Stocks to Crash

Related news

Select what you want to create

Image Post

Prompt to Post

Audio Post

Video Post

Multi-News Carousel

Upload and Schedule

Blog Post

AI Anchor Video

Newsroom FAQs